open access

Vol 64, No 2 (2006)
Other
Published online: 2006-02-16
Submitted: 2012-12-28
Get Citation

ORIGINAL ARTICLE
Monogenic hypercholesterolaemias – an evaluation of apolipoprotein B100 and LDL receptor gene polymorphisms

Robert Plewa, Michał Łuczak, Paweł Burchardt, Andrzej Bolewski, Jerzy Wierzchowiecki, Tomasz Siminiak
Kardiol Pol 2006;64(2):127-133.

open access

Vol 64, No 2 (2006)
Other
Published online: 2006-02-16
Submitted: 2012-12-28

Abstract

Introduction:Normally the N-terminal domain of the LDL receptor (LDLR) binds to low-density lipoprotein through apolipoprotein B100. Mutations within the LDL receptor and/or apolipoprotein B-100 genes compromising this process may lead to congenital monogenic hypercholesterolaemias known as familial hypercholesterolaemia or familial defective apolipoprotein B-100. These diseases are inherited as autosomal dominant traits. Aim: To search for LDLR and apoB100 gene mutations in a Polish population of patients with hypercholesterolaemia and to determine their types and locations. An attempt was also made to evaluate the influence of identified gene mutations on the modification of protein product sequence and the severity of its functional impairment. Methods: LDLR and apoB100 gene analyses using PCR, SSCP and automated sequencing techniques were performed in 190 hypercholesterolaemic patients. Flow cytometry was used to measure the influence of Cys152Trp mutation in the LDLR gene on ligand binding and internalisation. The OLA method was used for the preparation of adequate genetic markers allowing rapid detection of one of the most deleterious mutations of the apoB100 gene. Results and conclusions: Three brand new mutations, not reported so far, have been detected – Pro2712Leu and Ile3532 in the apoB100 gene, and Cys347Ser in the LDLR gene – and numerous changes in the nucleotide sequence of the LDL receptor gene have been confirmed. The observations of functionality of the mutated receptor gene with flow cytometry suggested the dysfunction of LDLR due to Cys152Trp polymorphism reported in many studies.

Abstract

Introduction:Normally the N-terminal domain of the LDL receptor (LDLR) binds to low-density lipoprotein through apolipoprotein B100. Mutations within the LDL receptor and/or apolipoprotein B-100 genes compromising this process may lead to congenital monogenic hypercholesterolaemias known as familial hypercholesterolaemia or familial defective apolipoprotein B-100. These diseases are inherited as autosomal dominant traits. Aim: To search for LDLR and apoB100 gene mutations in a Polish population of patients with hypercholesterolaemia and to determine their types and locations. An attempt was also made to evaluate the influence of identified gene mutations on the modification of protein product sequence and the severity of its functional impairment. Methods: LDLR and apoB100 gene analyses using PCR, SSCP and automated sequencing techniques were performed in 190 hypercholesterolaemic patients. Flow cytometry was used to measure the influence of Cys152Trp mutation in the LDLR gene on ligand binding and internalisation. The OLA method was used for the preparation of adequate genetic markers allowing rapid detection of one of the most deleterious mutations of the apoB100 gene. Results and conclusions: Three brand new mutations, not reported so far, have been detected – Pro2712Leu and Ile3532 in the apoB100 gene, and Cys347Ser in the LDLR gene – and numerous changes in the nucleotide sequence of the LDL receptor gene have been confirmed. The observations of functionality of the mutated receptor gene with flow cytometry suggested the dysfunction of LDLR due to Cys152Trp polymorphism reported in many studies.
Get Citation

Keywords

familial hypercholesterolaemia; familial defective apolipoprotein B-100 hypercholesterolaemia; dyslipidaemias

About this article
Title

ORIGINAL ARTICLE
Monogenic hypercholesterolaemias – an evaluation of apolipoprotein B100 and LDL receptor gene polymorphisms

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 64, No 2 (2006)

Pages

127-133

Published online

2006-02-16

Bibliographic record

Kardiol Pol 2006;64(2):127-133.

Keywords

familial hypercholesterolaemia
familial defective apolipoprotein B-100 hypercholesterolaemia
dyslipidaemias

Authors

Robert Plewa
Michał Łuczak
Paweł Burchardt
Andrzej Bolewski
Jerzy Wierzchowiecki
Tomasz Siminiak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl